Speaker
Chief Scientific Officer, MitoRx Therapeutics Limited
Xavier Jacq, Chief Scientific Officer, MitoRx Therapeutics Limited, spoke at 2nd Obesity & Weight Loss Drug Development Summit Europe (Munich, Germany, 28–29 Oct 2026) in the session “Targeting Mitochondrially Unhealthy Obesity to Provide an Alternative Mode of Action for Obesity Therapeutics”.
Translational Research Associate, Resalis Therapeutics
Director - Scientific, Gubra
Chief Executive & Scientific Officer, iBio
VP of Research & Development, Constructive Bio
Head of Project Management, Cytoo
Professor, University of Aberdeen
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Xavier Jacq, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].